Isorhyncophylline Targets PP2AC to Modulate YAP to Inhibit Endothelial Cell Inflammation
Phytotherapy Research · 2026
DOI: 10.1002/ptr.70246 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, 2026. Verfasst von Lihua Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China. Hauptthemen laut MEDLINE: Inflammation, Oxindoles, Protein Phosphatase 2, Adaptor Proteins, Signal Transducing. Die Arbeit nennt 58 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, Twenty Rules for Colleges and Universities of Jinan, Clinical Medical Science and Technology Innovation Program.
Abstract (Originalsprache)
Atherosclerosis (AS) constitutes the pathological basis of multiple cardiovascular diseases, predisposing to severe clinical complications. Isorhynchophylline (IRN), a principal bioactive alkaloid derived from Uncaria rhynchophylla, exhibits anti‐inflammatory properties, yet its therapeutic potential and molecular mechanisms in AS remain unexplored. Scratch wound healing and Transwell migration assays were conducted to evaluate the effects of monomer compounds on cellular migratory and invasive capabilities. The changes in mRNA and protein expression levels of inflammation genes were determined using RT‐PCR and western blot analyses, respectively. Molecular docking and drug affinity responsive target stability analyses were performed to assess the binding affinity of IRN and PP2AC. Our findings demonstrate that IRN treatment effectively ameliorates atherosclerotic plaque progression and mitigates endothelial inflammation. The underlying mechanism involves the binding of IRN to PP2AC and the subsequent regulation of YAP activity. This study underscores the therapeutic potential of IRN in alleviating inflammation and its promise as a treatment for AS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China.
- Institute of Traditional Chinese Medicine Analysis, Shandong Academy of Chinese Medicine, Jinan, China.
- Innovative Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China.
- First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China.
- Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Key Laboratory of Traditional Chinese Medicine Classical Theory, Ministry of Education, Shandong University of Traditional Chinese Medicine, Jinan, China.
ORCID-Profile: Yuanlong Hu, Desheng Hu, Haiqiang Jiang
Förderung
- Natural Science Foundation of Shandong Province
- Twenty Rules for Colleges and Universities of Jinan
- Clinical Medical Science and Technology Innovation Program
- Introduction and Education Program for Young Talents in Shandong Colleges and Universities
- the Outstanding Youth Innovation Team of Shandon Institutions of Higher Learning
Zitieren
APA
Wang, L., Liu, Y., Li, H., Yu, W., Hu, Y., Hu, D., Jiang, H., Zhu, X., & Wang, D. (2026). Isorhyncophylline Targets PP2AC to Modulate YAP to Inhibit Endothelial Cell Inflammation. Phytotherapy Research. https://doi.org/10.1002/ptr.70246
Vancouver
Wang L, Liu Y, Li H, Yu W, Hu Y, Hu D, et al. Isorhyncophylline Targets PP2AC to Modulate YAP to Inhibit Endothelial Cell Inflammation. Phytotherapy Research. 2026. doi:10.1002/ptr.70246
BibTeX
@article{Wang2026,
author = {Wang, Lihua and Liu, Yuecheng and Li, Haichao and Yu, Wenchi and Hu, Yuanlong and Hu, Desheng and Jiang, Haiqiang and Zhu, Xialin and Wang, Danyang},
title = {Isorhyncophylline Targets PP2AC to Modulate YAP to Inhibit Endothelial Cell Inflammation},
journal = {Phytotherapy Research},
year = {2026},
doi = {10.1002/ptr.70246}
}
EUVIMED